Pee Cee Cosma Sope [PCCOSMA] vs Hindustan Unilever [HINDUNILVR] Detailed Stock Comparison

Pee Cee Cosma Sope
BSE
Loading...

Hindustan Unilever
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Pee Cee Cosma Sope wins in 7 metrics, Hindustan Unilever wins in 11 metrics, with 0 ties. Hindustan Unilever appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Pee Cee Cosma Sope | Hindustan Unilever | Better |
---|---|---|---|
P/E Ratio (TTM) | 12.70 | 54.56 | Pee Cee Cosma Sope |
Price-to-Book Ratio | 2.52 | 11.93 | Pee Cee Cosma Sope |
Debt-to-Equity Ratio | 3.39 | 3.32 | Hindustan Unilever |
PEG Ratio | N/A | 15.10 | N/A |
EV/EBITDA | 8.33 | 40.56 | Pee Cee Cosma Sope |
Profit Margin (TTM) | 6.36% | 16.89% | Hindustan Unilever |
Operating Margin (TTM) | 9.77% | 20.33% | Hindustan Unilever |
EBITDA Margin (TTM) | 9.77% | 20.33% | Hindustan Unilever |
Return on Equity | 19.84% | 21.47% | Hindustan Unilever |
Return on Assets (TTM) | 16.67% | 13.33% | Pee Cee Cosma Sope |
Free Cash Flow (TTM) | $61.86M | $106.11B | Hindustan Unilever |
Dividend Yield | 0.43% | 92.12% | Hindustan Unilever |
1-Year Return | -21.07% | -8.36% | Hindustan Unilever |
Price-to-Sales Ratio (TTM) | 0.85 | 9.22 | Pee Cee Cosma Sope |
Enterprise Value | $1.23B | $5,778.71B | Hindustan Unilever |
EV/Revenue Ratio | 0.85 | 9.04 | Pee Cee Cosma Sope |
Gross Profit Margin (TTM) | 23.48% | 49.51% | Hindustan Unilever |
Revenue per Share (TTM) | $546 | $272 | Pee Cee Cosma Sope |
Earnings per Share (Diluted) | $36.39 | $45.97 | Hindustan Unilever |
Beta (Stock Volatility) | N/A | 0.37 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Pee Cee Cosma Sope vs Hindustan Unilever Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Pee Cee Cosma Sope | 2.75% | 0.28% | 1.75% | -20.19% | -16.58% | -21.53% |
Hindustan Unilever | 0.45% | -2.01% | -1.30% | 4.25% | 6.49% | 6.96% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Pee Cee Cosma Sope | -21.07% | 292.95% | 382.21% | 761.45% | 440.36% | 630.22% |
Hindustan Unilever | -8.36% | -4.41% | 14.37% | 184.84% | 836.56% | 1,401.73% |
Performance & Financial Health Analysis: Pee Cee Cosma Sope vs Hindustan Unilever
Metric | PCCOSMA | HINDUNILVR |
---|---|---|
Market Information | ||
Market Cap | ₹1.22B | ₹5.89T |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 786 | 1,694,958 |
90 Day Avg. Volume | 1,527 | 1,604,830 |
Last Close | ₹476.00 | ₹2,495.10 |
52 Week Range | ₹435.05 - ₹978.60 | ₹2,136.00 - ₹3,035.00 |
% from 52W High | -51.36% | -17.79% |
All-Time High | ₹978.60 (Oct 07, 2024) | ₹3,035.00 (Sep 23, 2024) |
% from All-Time High | -51.36% | -17.79% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.03% | 0.05% |
Quarterly Earnings Growth | -0.13% | 0.06% |
Financial Health | ||
Profit Margin (TTM) | 0.06% | 0.17% |
Operating Margin (TTM) | 0.10% | 0.20% |
Return on Equity (TTM) | 0.20% | 0.21% |
Debt to Equity (MRQ) | 3.39 | 3.32 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹183.28 | ₹210.26 |
Cash per Share (MRQ) | N/A | ₹47.04 |
Operating Cash Flow (TTM) | ₹49.99M | ₹133.75B |
Levered Free Cash Flow (TTM) | ₹96.38M | ₹106.49B |
Dividends | ||
Last 12-Month Dividend Yield | 0.43% | 92.12% |
Last 12-Month Dividend | ₹2.00 | ₹2,095.79 |
Valuation & Enterprise Metrics Analysis: Pee Cee Cosma Sope vs Hindustan Unilever
Metric | PCCOSMA | HINDUNILVR |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 12.70 | 54.56 |
Forward P/E | N/A | 49.85 |
PEG Ratio | N/A | 15.10 |
Price to Sales (TTM) | 0.85 | 9.22 |
Price to Book (MRQ) | 2.52 | 11.93 |
Market Capitalization | ||
Market Capitalization | ₹1.22B | ₹5.89T |
Enterprise Value | ₹1.23B | ₹5.78T |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.85 | 9.04 |
Enterprise to EBITDA | 8.33 | 40.56 |
Risk & Other Metrics | ||
Beta | N/A | 0.37 |
Book Value per Share (MRQ) | ₹183.28 | ₹210.26 |
Financial Statements Comparison: Pee Cee Cosma Sope vs Hindustan Unilever
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | PCCOSMA | HINDUNILVR |
---|---|---|
Revenue/Sales | ₹392.32M | ₹163.23B |
Cost of Goods Sold | ₹300.21M | ₹82.41B |
Gross Profit | ₹92.12M | ₹80.82B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹9.75M | ₹33.57B |
EBITDA | ₹15.50M | ₹39.18B |
Pre-Tax Income | ₹9.51M | ₹33.03B |
Income Tax | ₹2.71M | ₹5.35B |
Net Income (Profit) | ₹6.63M | ₹27.68B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | PCCOSMA | HINDUNILVR |
---|---|---|
Cash & Equivalents | ₹5.95M | ₹60.71B |
Total Current Assets | ₹284.50M | ₹220.51B |
Total Current Liabilities | ₹85.08M | ₹165.37B |
Long-Term Debt | ₹4.24M | ₹12.43B |
Total Shareholders Equity | ₹485.68M | ₹496.09B |
Retained Earnings | N/A | ₹86.22B |
Property, Plant & Equipment | ₹148.38M | ₹16.66B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | PCCOSMA | HINDUNILVR |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | PCCOSMA | HINDUNILVR |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 786 | 1,694,958 |
Average Daily Volume (90 Day) | 1,527 | 1,604,830 |
Shares Outstanding | 2.65M | 2.35B |
Float Shares | 1.54M | 873.48M |
% Held by Insiders | 0.75% | 0.62% |
% Held by Institutions | 0.00% | 0.19% |
Dividend Analysis & Yield Comparison: Pee Cee Cosma Sope vs Hindustan Unilever
Metric | PCCOSMA | HINDUNILVR |
---|---|---|
Last 12-Month Dividend | ₹2.00 | ₹2,095.79 |
Last 12-Month Dividend Yield | 0.43% | 92.12% |
3-Year Avg Annual Dividend | ₹2.00 | ₹725.60 |
3-Year Avg Dividend Yield | 0.64% | 15.79% |
3-Year Total Dividends | ₹6.00 | ₹2,176.79 |
Ex-Dividend Date | Sep 20, 2024 | Jun 23, 2025 |